Metrics as of 10/13/2026, 06:55 PM (Berlin time), refresh in progress.
Senseonics Holdings, Inc.
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core…
1D
-1.4%
1W
-8.5%
1M
+4.6%
6M
+35.0%
YTD
+65.1%
1Y
+8.8%
2Y
+28.7%
5Y
-85.8%
10Y
-86.6%
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~36% stronger price swings than usual
PRICE TARGET LOW
US$8.00
CONSENSUS
US$13.00
MEDIAN
US$14.00
PRICE TARGET HIGH
US$18.00
0
STRONG BUY
9
BUY
5
HOLD
3
SELL
0
STRONG SELL
17
TOTAL · Buy
As of: 15/07/2026
P/E
-4.02
P/B
5.84
EV/EBITDA
-3.89
RETURN ON EQUITY
-40.6%
NET MARGIN
-253.4%
DEBT/EQUITY
0.68
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
92.1%
FLOAT SHARES
38,471,891
AVG. DAILY VOLUME (30D)
690,468
Prince Douglas S
Fiorentino Edward
ROEDER DOUGLAS A
Steven Edelman
ROEDER DOUGLAS A
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.4%
Forums (Reddit)
Senseonics Holdings, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Timothy T. Goodnow, the company employs around 130 people.
The IPO was on 22/12/2015; the stock trades on NASDAQ under the ticker SENS.
17 analysts rate the stock, the consensus is Buy (as of 15/07/2026).
The average price target is US$13.00, ranging from US$8.00 to US$18.00, with a median of US$14.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 36% stronger than usual.
No, Senseonics Holdings currently does not pay a dividend.
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
Clicking "Analyze stock" lets five strategies assess Senseonics Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.